Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
29.8%
% of IHI's 48 holdings also in FMED
25.0%
% of FMED's 61 holdings also in IHI
Overlap by Weight
Sector Drift (IHI minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IHI |
Weight in FMED |
Overlap | |
---|---|---|---|---|
BOSTON SCIENTIFIC CORP | 11.7% | 6.6% | 6.6% | |
INTUITIVE SURGICAL INC | 16.3% | 4.6% | 4.6% | |
STRYKER CORP | 4.4% | 2.7% | 2.7% | |
EDWARDS LIFESCIENCES CORP | 4.5% | 2.3% | 2.3% | |
INSULET CORP | 2.2% | 4.5% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
IHI Overweight Relative to FMED
ABBOTT LABORATORIES | 16.2% | |
INTUITIVE SURGICAL INC | 11.7% | |
BOSTON SCIENTIFIC CORP | 5.0% | |
BECTON DICKINSON AND CO | 4.8% | |
GE HEALTHCARE TECHNOLOGIES INC. | 4.4% | |
MEDTRONIC PLC | 4.4% | |
IDEXX LABORATORIES INC | 3.9% | |
RESMED INC | 2.6% | |
ZIMMER HOLDINGS INC | 2.4% | |
STERIS PLC | 2.3% |
IHI Underweight Relative to FMED
UNITEDHEALTH GROUP INC | -4.1% | |
DANAHER CORP | -3.8% | |
ARGENX SE ADR | -3.6% | |
EXACT SCIENCES CORP | -3.2% | |
REGENERON PHARMACEUTICALS | -3.0% | |
UCB SA | -2.8% | |
ALNYLAM PHARMACEUTICALS INC | -2.7% | |
LIFESTANCE HEALTH GROUP, INC. | -2.6% | |
INSULET CORP | -2.4% | |
LEGEND BIOTECH CORPORATION SPONSORED | -2.3% |